ZIC
TMDX icon

ZWJ Investment Counsel’s Transmedics TMDX Stock Holding History

ZWJ Investment Counsel’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,100
Closed -$236K – 254
2025
Q3 		$236K Buy
+2,100
New +$246K 0.01% 218

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

ZWJ Investment Counsel's TMDX Position: Q4 2025 in Review

ZWJ Investment Counsel sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 2,100 shares — an estimated $236K sold.

ZWJ Investment Counsel first reported a position in TMDX in Q3 2025 and held it in 1 quarter. The position peaked at $236K in Q3 2025. 429 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • ZWJ Investment Counsel reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • ZWJ Investment Counsel sold 2,100 Transmedics shares in Q4 2025, an estimated $236K.
  • ZWJ Investment Counsel first reported a position in Transmedics in Q3 2025 and held it in 1 quarter.
  • ZWJ Investment Counsel's Transmedics position peaked at $236K in Q3 2025.
  • 429 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on ZWJ Investment Counsel's 13F filing for Q4 2025, filed 23 Jan 2026.